- Home
- NSRX vs CLPR Comparison
NSRX vs CLPR Comparison
Compare NSRX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSRX | CLPR |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | Israel | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 46.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | NSRX | CLPR |
|---|---|---|
| Price | $3.08 | $2.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | 20.6K | ★ 169.8K |
| Earning Date | 03-25-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 10.73% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,997,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.82 |
| 52 Week Low | $1.98 | $2.69 |
| 52 Week High | $9.99 | $4.61 |
Technical Indicators
Market Signals| Indicator | NSRX | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 45.84 |
| Support Level | $2.78 | $2.81 |
| Resistance Level | $3.58 | $3.28 |
| Average True Range (ATR) | 0.22 | 0.14 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 0.00 | 42.95 |
Price Performance
Historical ComparisonAbout NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.